Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
| pharmaceutical_companies:bavarian_nordic [2022/06/21 01:39] liam | pharmaceutical_companies:bavarian_nordic [2022/07/07 09:09] (current) liam [Biosecurity] | ||
|---|---|---|---|
| Line 5: | Line 5: | ||
| **Bavarian Nordic** is a Danish biotechnology company based in [[europe: | **Bavarian Nordic** is a Danish biotechnology company based in [[europe: | ||
| + | ===== History ===== | ||
| + | |||
| + | On May 6, 2022, the company was awarded a contract by the [[:Public Health Agency of Canada]] (PHAC) to provide 500,000 units of Imvamune to the Canadian stockpile.((Public Services and Procurement Canada. (2022, April 21). //Third Generation Smallpox Vaccine (6D024-215700/ | ||
| + | |||
| + | ===== Affiliations ===== | ||
| + | |||
| + | ==== Biosecurity ==== | ||
| + | |||
| + | Bavarian Nordic is a funding partner of the [[: | ||
| + | |||
| + | Additionally, | ||
| ===== Products ===== | ===== Products ===== | ||
| ==== Smallpox ==== | ==== Smallpox ==== | ||
| - | Bavarian Nordic manufactures a [[smallpox vaccine]] product named Imvamune (Canada), Imvanex (Europe), or Jynneos | + | Bavarian Nordic manufactures a [[:smallpox vaccine]] product named Imvamune ([[:Canada]]), Imvanex ([[Europe]]), or Jynneos |